FormBlends Calculators: Dosing arithmetic, shown step by step.
formblendscalculator.com
LaunchIndex first observed FormBlends Calculators: Dosing arithmetic, shown step by step. (formblendscalculator.com) live on 1 October 2026. View its launch screenshot, category, technologies, and verification evidence.

A launch record built from evidence.
FormBlends Calculators: Dosing arithmetic, shown step by step. (formblendscalculator.com) was first observed live on 1 October 2026.
Browser-based GLP-1 medication calculators and guides, including dose conversion, injection schedules, weight projections, cost per mg, BMI context, and protein targets.
Its profile is classified as Saas within Health / Health and wellness. Verification detected Next.js and Google Analytics.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- formblendscalculator.com
- Category
- Health / Health and wellness
- Website type
- Saas
- Observed title
- FormBlends Calculators: Dosing arithmetic, shown step by step.
- Observed description
- Free browser-based calculators for prescribed GLP-1 medication: dose unit conversion, injection schedules, weight-loss projections from published trials, cost per mg, BMI context and protein targets. Every tool shows its formula and its sources.
- Detected technologies
- Next.jsGoogle Analytics
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.